October 27, 2022
Stacking Discounts for Best Price, PHS & 340B, HHS Ruling
3 Minute Read
Regulatory and legal updates on three significant regulatory topics, including stacking of discounts for best price, PHS and 340B.
Blog
September 27, 2022
FSS Public Law, US Territory Inclusion, and Branded Prescription Fee Invoice
4 Minute Read
Regulatory and legal updates on four significant regulatory topics, including the Inflation Reduction Act and FSS Public Law updates.
August 29, 2022
The Impact of the Inflation Reduction Act on the Pharmaceutical Industry
4 Minute Read
Explore some of the key provisions and timelines of the Inflation Reduction Act for their impact on pharmaceutical manufacturers government pricing and GTN strategies.
August 19, 2022
NDC Format Proposal, Focus on PBMs, False Claims Act
4 Minute Read
August's market update is a legislative review of the NDC formal proposal, FTC investigation of PBMs, and the False Claims Act.
July 19, 2022
Legal Review: Medicare Program, 340B, and State Price Updates
6 Minute Read
July's market update is a legislative review of 340B contract pharmacy restrictions, new Medicare bills, and SPTR updates.
July 13, 2022
Top Trends in Specialty Network and Service Design
5 Minute Read
Benchmarks on specialty networks using our exclusive ICyte channel and patient access data: what specialty networks look like, who's included, and how network sizes vary by therapeutic category.
June 27, 2022
Pharma vs. 340B
4 Minute Read
This month’s market update features the latest news detailing the tumultuous relationship between pharma and 340B, including The Supreme Court, HRSA, and insight on how inflation escalates everything.
June 14, 2022
Top Trends in Contracting
6 Minute Read
Using exclusive ICyte Benchmarks from over 230 brands across more than 50 manufacturers, we examine the top trends in specialty pharmacy contracting.
June 7, 2022
Best Practices: Identifying and Avoiding Patient Access Barriers
4 Minute Read
Market access leaders from DBV Technologies, Sesen Bio, and Karyopharm Therapeutics discuss strategies to overcome obstacles to patient initiation and adherence.